...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
【24h】

Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.

机译:microRNA在人类肝细胞癌中的诊断和预后意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs) are important gene regulators, which are often deregulated in cancers. In this study, the authors analyzed the microRNAs profiles of 78 matched canceroncanerous liver tissues from HCC patients and 10 normal liver tissues and found that 69 miRNAs were differentially expressed between hepatocellular carcinoma (HCC) and corresponding noncancerous liver tissues (N). Then the expressions of 8 differentially expressed miRNAs were validated by real time RT PCR. The set of differentially expressed miRNAs could distinctly classify HCC, N and normal liver tissues (NL). Moreover, some of these differentially expressed miRNAs were related to the clinical factors of HCC patients. Most importantly, Kaplan-Meier estimates and the log-rank test showed that high expression of hsa-miR-125b was correlated with good survival of HCC patients (hazard ratio, 1.787, 95% confidence interval, 1.020-3.133, p = 0.043). The transfection assay showed that overexpression of miR-125b in HCC cell line could obviously suppress the cell growth and phosporylation of Akt. In conclusion, the authors have demonstrated the diagnostic miRNA profile for HCC, and for the first time, identified the miR-125b with predictive significance for HCC prognosis.
机译:微小RNA(miRNA)是重要的基因调节剂,在癌症中通常被放松调节。在这项研究中,作者分析了来自HCC患者的78个匹配的癌/非癌肝组织和10个正常肝组织的microRNA图谱,发现69个miRNA在肝细胞癌(HCC)和相应的非癌肝组织(N)之间差异表达。然后通过实时RT PCR验证8种差异表达的miRNA的表达。这组差异表达的miRNA可以将HCC,N和正常肝组织(NL)明确分类。而且,这些差异表达的miRNA中的一些与HCC患者的临床因素有关。最重要的是,Kaplan-Meier估计和对数秩检验表明,hsa-miR-125b的高表达与HCC患者的良好生存相关(危险比,1.787,95%置信区间,1.020-3.133,p = 0.043) 。转染实验表明,miR-125b在肝癌细胞系中的过度表达可以明显抑制Akt的细胞生长和磷酸化。总之,作者已经证明了HCC的诊断miRNA谱,并且首次鉴定了对RCC预后具有预测意义的miR-125b。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号